日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and efficacy of fruquintinib-based therapy in patients with advanced or metastatic sarcoma

呋喹替尼治疗晚期或转移性肉瘤患者的安全性和有效性

Zhou, Chenliang; Qian, Guowei; Wang, Yonggang; Li, Hongtao; Shen, Zan; Zheng, Shuier

A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas

一项针对晚期骨和软组织肉瘤患者的多抗原刺激细胞疗法-I联合卡瑞利珠单抗和阿帕替尼的初步研究

Zhou, Yan; Li, Mei; Zhang, Bing; Yang, Cheng; Wang, Yaling; Zheng, Shuier; Tang, Lina; Zhou, Chenliang; Qian, Guowei; Huang, Yujing; Yu, Wenxi; Li, Hongtao; Wang, Yonggang; He, Aina; Shen, Zan; Zhang, Jianjun; Li, Xiaoshuang; Yang, Qingcheng; Hu, Haiyan; Yao, Yang

Oncometabolite D-2-hydroxyglutarate-dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia

肿瘤代谢物 D-2-羟基戊二酸依赖性代谢重编程在癌症恶病质期间诱导骨骼肌萎缩

Xinting Zhu #, Juan Hao #, Hong Zhang, Mengyi Chi, Yaxian Wang, Jinlu Huang, Rong Xu, Zhao Xincai, Bo Xin, Xipeng Sun, Jianping Zhang, Shumin Zhou, Dongdong Cheng, Ting Yuan, Jun Ding, Shuier Zheng, Cheng Guo, Quanjun Yang

Correction: TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

更正:TRIM6 通过 TIS21/FoxM1 促进结直肠癌细胞增殖和对硫链丝菌素的反应

Zheng, Shuier; Zhou, Chenliang; Wang, Yonggang; Li, Hongtao; Sun, Yong; Shen, Zan

D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment

D2HGDH 介导的 D2HG 分解代谢增强了免疫抑制微环境中 CAR-T 细胞的抗肿瘤活性

Quanjun Yang, Juan Hao, Mengyi Chi, Yaxian Wang, Jie Li, Jinlu Huang, Jianping Zhang, Mengqi Zhang, Jin Lu, Shumin Zhou, Ting Yuan, Zan Shen, Shuier Zheng, Cheng Guo

Surgical Management of Cardiac Masses in Right Atrium Among Bone Sarcoma Pediatric Patients With Totally Implanted Ports

骨肉瘤患儿右心房心脏肿块的外科治疗:全植入式输液港的治疗

Zhou, Chenliang; Wang, Yiyun; Chen, Zonghui; Qian, Guowei; Yu, Wenxi; Wang, Yong; Zheng, Shuier; Shen, Zan; Li, Hongtao; Wang, Yonggang

Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden

病例报告:序贯化疗和免疫疗法对高肿瘤突变负荷的骨肉瘤产生持续缓解

Zheng, Shuier; Wang, Fenglin; Huang, Jin; Zhou, Yan; Yang, Quanjun; Qian, Guowei; Zhou, Chenliang; Min, Daliu; Song, Lele; Shen, Zan

TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

TRIM6 通过 TIS21/FoxM1 促进结直肠癌细胞增殖和对硫链丝菌素的反应

Shuier Zheng #, Chenliang Zhou #, Yonggang Wang, Hongtao Li, Yong Sun, Zan Shen

N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1

TRIM7 的 N6-甲基腺苷修饰通过 BRMS1 泛素化正向调节骨肉瘤的肿瘤发生和化学耐药性

Chenliang Zhou, Zhichang Zhang, Xiaoshi Zhu, Guowei Qian, Yan Zhou, Yong Sun, Wenxi Yu, Jiahui Wang, Haiyang Lu, Feng Lin, Zan Shen, Shuier Zheng